| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 60.9% | -10.86% | -0.04% | 44/157 | 48.88% | 海创药业 | 97.34% | 行业排名> |
| 2026-03-31 | 60.93% | -6.89% | -6.27% | 54/157 | 50.55% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 65% | -0.94% | -2.6% | 39/157 | 50.61% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 66.74% | 1.34% | -2.31% | 37/157 | -2.2% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 68.32% | 2.64% | 4.41% | 36/157 | 14.82% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 65.43% | 2% | -0.28% | 36/157 | 31.96% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 65.61% | 0.23% | -0.37% | 41/157 | 51.88% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 65.86% | 2% | -1.06% | 40/157 | 22.51% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 66.56% | 13.97% | 1.68% | 39/157 | 33.12% | 百利天恒 | 97.99% | 行业排名> |
| 2023-12-31 | 65.46% | 10.88% | 10.88% | 40/157 | 51.61% | 百利天恒 | 98.92% | 行业排名> |
| 2022-12-31 | 59.04% | -6.81% | 1.09% | 58/157 | 53.83% | 迈威生物 | 98.93% | 行业排名> |
| 2022-06-30 | 58.4% | 2% | -7.81% | 61/157 | 20.99% | 迈威生物 | 99.59% | 行业排名> |
| 2021-12-31 | 63.35% | 2% | 2% | 56/157 | 55.2% | 迈威生物 | 99.8% | 行业排名> |

微信公众号
证券之星APP


